Determination of the optical purity of N-nitrosofenfluramine found in the chinese slimming diet

被引:15
作者
Nakadai, A
Inagaki, H
Minami, M
Takahashi, H
Namme, R
Ohsawa, M
Ikegami, S
机构
[1] Nippon Med Coll, Dept Hyg & Publ Hlth, Bunkyo Ku, Tokyo 1138602, Japan
[2] Teikyo Univ, Fac Pharmaceut Sci, Sagamiko, Kanagawa 1990195, Japan
来源
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN | 2003年 / 123卷 / 09期
关键词
fenfluramine; anorectic drug; optical purity; chiral; Chinese diet; N-nitrosofenfluramine;
D O I
10.1248/yakushi.123.805
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
From 2001 to the summer of 2002, more than 800 cases of liver damage were reported in Japan among people taking Chinese diet aids. The Japanese Ministry of Health, Labor and Welfare has recently announced that N-nitrosofenfluramine was the hepatotoxic compound contained in the diet aids based on animal experiments performed by the National Institute of Health Sciences. Although N-nitrosofenfluramine is a derivative of fenfluramine, a previously used anti-obesity drug, neither pharmacologic nor toxicologic properties have been reported for N-nitrosofenfluramine. It should be noted that N-nitrosofenfluramine has two optical isomers, although it is not yet known which isomer damages the liver and other organs. The Japanese Ministry of Health, Labor and Welfare has not commented on this point. Pursuing this question, 10 types of Chinese slimming aid samples including those obtained from patients with fulminating hepatitis were analyzed by NMR, GC/MS, and a newly established HPLC method using a chiral separation column. It was found that the N-nitrosofenfluramine in all of the toxic diet aids was the (S)-isomer form. No (R)-isomer was detected. These results strongly suggest that the nitroso-compound in the diets must be prepared from pharmacologically active (S)-fenfluramine (dexfenfluramine). Thus the pharmacologic and toxicologic properties of each isomer should be investigated.
引用
收藏
页码:805 / 809
页数:5
相关论文
共 6 条
[1]   Valvular heart disease associated with fenfluramine-phentermine [J].
Connolly, HM ;
Crary, JL ;
McGoon, MD ;
Hensrud, DD ;
Edwards, BS ;
Edwards, WD ;
Schaff, HV .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (09) :581-588
[2]   STRUCTURAL STUDIES BY NUCLEAR MAGNETIC RESONANCE .9. CONFIGURATIONS + CONFORMATIONS OF N-NITROSAMINES [J].
KARABATSOS, GJ ;
TALLER, RA .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1964, 86 (20) :4373-&
[3]  
LANGRETH R, 1997, WALL STREET J B, V8
[4]  
Morehead AT, 1996, ENANTIOMER, V1, P63
[5]   EFFECT OF FENFLURAMINE ON OBESE, MATURITY-ONSET DIABETIC-PATIENTS [J].
WALES, JK .
ACTA ENDOCRINOLOGICA, 1979, 90 (04) :616-623
[6]   A DOUBLE-BLIND CLINICAL-TRIAL IN WEIGHT CONTROL - USE OF FENFLURAMINE AND PHENTERMINE ALONE AND IN COMBINATION [J].
WEINTRAUB, M ;
HASDAY, JD ;
MUSHLIN, AI ;
LOCKWOOD, DH .
ARCHIVES OF INTERNAL MEDICINE, 1984, 144 (06) :1143-1148